Answers are grounded in this paper and cite their sources.
G protein-coupled receptors (GPCRs) are capable of downstream signaling through distinct noncanonical pathways such as β-arrestins in addition to the canonical G protein-dependent pathways. GPCR ligands that differentially activate the downstream signaling pathways are termed functionally selective or biased ligands. A class of novel non-catechol G protein-biased agonists of the dopamine D 1 receptor (D 1 R) was recently disclosed. We conducted the first comprehensive structure–functional selectivity relationship study measuring G S and β-arrestin2 recruitment activities focused on four regions of this scaffold, resulting in over 50 analogs with diverse functional selectivity profiles. Some compounds became potent full agonists of β-arrestin2 recruitment, while others displayed enhanced G S bias compared to the starting compound. Pharmacokinetic testing of an analog with an altered functional selectivity profile demonstrated excellent blood–brain barrier penetration. This study provides novel tools for studying ligand bias at D 1 R and paves the way for developing the next generation of biased D 1 R ligands.
No takes yet. Share an insight, caveat, or question.
Martini et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: